Meghana Keshavan

Meghana Keshavan

Meghana has spent the last year-and-a-half writing about biotech and healthcare for the San Diego Business Journal. Previously, she's worked for Reuters, Crain’s Detroit Business, the Detroit Free Press and WDET, a Detroit-based National Public Radio affiliate. Meghana studied biochemistry and molecular biology at Penn State University and spent five years as a self-described "research peon in a schizophrenia genetics lab."

Follow Meghana Keshavan: Twitter |


San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy

San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy

April 18, 2015 11:20 am by | 0 Comments

San Diego biotech Glycoregimmune is working on a way to inhibit the natural killer T cells that exacerbate the inflammatory response and hepatic injury that stems from liver disease. Natural killer T cells…


Stealth San Diego startup Metacrine raising $33M. Are we reassembling the Seragon team?

Stealth San Diego startup Metacrine raising $33M. Are we reassembling the Seragon team?

April 17, 2015 3:21 pm by | 0 Comments

An interesting new San Diego biotech – Metacrine – is in the works. CFO Trisha Millican said the company’s raised $6.85 million, and is aiming for $33 million – but otherwise is…



A topical way to treat migraines with NSAIDs – and cut down on all those GI bleeds

A topical way to treat migraines with NSAIDs – and cut down on all those GI bleeds

April 17, 2015 1:32 pm by | 0 Comments

There are only so many Advils a migraineur can pop before the ulcers and GI bleeds start setting in. They may be effective pain drugs, but NSAIDs are notorious for…


With new $280M fund, Atlas Venture cuts the IT and “right-sizes” to biotech

With new $280M fund, Atlas Venture cuts the IT and “right-sizes” to biotech

April 17, 2015 10:09 am by | 0 Comments

Atlas Venture just closed its tenth fund at $280 million – marking its switch over to a biotech-only firm, the firm’s Bruce Booth blogged today. “At our core, we’re biotech…


A step up from Dr. Scholl’s: Baltimore devicemaker raises $2.9M for cryotherapy that freezes off malignant internal tissue

A step up from Dr. Scholl’s: Baltimore devicemaker raises $2.9M for cryotherapy that freezes off malignant internal tissue

April 16, 2015 6:59 pm by | 0 Comments

A well-funded Baltimore startup whose spray cryotechnology flash-freezes unwanted or malignant tissues inside the body just raised a touch more capital. According to a regulatory filing, CSA Medical just raised…


Medical devices are facing tougher scrutiny – from regulators, and insurers too

Medical devices are facing tougher scrutiny – from regulators, and insurers too

April 16, 2015 1:45 pm by | 0 Comments

Medical devices are coming under closer regulatory scrutiny, with U.S. health insurers calling for more stringent control over how reusable devices are approved, monitored and maintained. The most recent waves come…


How much of NEA’s new, $3.1 billion fund will finance healthcare companies? A third, perhaps.

How much of NEA’s new, $3.1 billion fund will finance healthcare companies? A third, perhaps.

April 15, 2015 6:51 pm by | 0 Comments

Venture firm New Enterprise Associates made some massive waves today on news that it’s closed its fifteenth – and largest – fund, which holds $3.1 billion. And a huge swath of that…



After withdrawing IPO, DermTech raises $2.4M for its RNA-based, biopsy-free melanoma diagnostic

After withdrawing IPO, DermTech raises $2.4M for its RNA-based, biopsy-free melanoma diagnostic

April 15, 2015 5:17 pm by | 0 Comments

San Diego skin cancer diagnostics startup DermTech is developing gene classifiers and expression tests to help more accurately screen for dermatologic issues. It just raised $2.4 million to do so, according to…


Startup raising $3M for drug approach that inhibits tau aggregation in Alzheimer’s disease

Startup raising $3M for drug approach that inhibits tau aggregation in Alzheimer’s disease

April 15, 2015 2:56 pm by | 0 Comments

Protein misfolding – and resultant tau aggregation – has long been fingered as causative of Alzheimer’s and other neurodegenerative disease. New York startup Oligomerix is addressing this issue with a host…


Specialty drugs are driving up the U.S. medication spend – indeed a prime revenue opp

Specialty drugs are driving up the U.S. medication spend – indeed a prime revenue opp

April 14, 2015 7:19 pm by | 0 Comments

Need proof that orphan indication’s the way to go? The demand for specialty medications – and their premium pricing – is driving up the total American spend on medication, a…


Duchenne Muscular Dystrophy market to shoot up 100-fold in five years

Duchenne Muscular Dystrophy market to shoot up 100-fold in five years

April 14, 2015 1:54 pm by | 0 Comments

As a whole host of new Duchenne Muscular Dystrophy therapies mature down the regulatory pathway, the global market for the degenerative disease is expected to expand at an incredible rate – from $8.2…


Baltimore startup building a portable, artificial lung – the first meant to be used out of a hospital

Baltimore startup building a portable, artificial lung – the first meant to be used out of a hospital

April 13, 2015 6:26 pm by | 0 Comments

Nearly 400,000 Americans die each year from lung disease. The just-formed University of Maryland spinout Breethe Inc. is building a wearable, portable blood pump oxygenator that’ll work as an artificial lung….


Cambridge gene therapy startup Voyager Therapeutics raises $60M for CNS disorders

Cambridge gene therapy startup Voyager Therapeutics raises $60M for CNS disorders

April 13, 2015 3:37 pm by | 0 Comments

Cambridge gene therapy startup Voyager Therapeutics just wrapped up a $60 million Series B round to advance its treatments for conditions of the CNS like ALS and Parkinson’s disease. Voyager is…


Is it a virus or a bacteria? New test may help curb unnecessary antibiotic prescription

Is it a virus or a bacteria? New test may help curb unnecessary antibiotic prescription

April 10, 2015 5:35 pm by | 1 Comments

A team of Israeli researchers have developed a test that can distinguish whether an infection stems from a virus or a bacteria – a simple but potentially impactful screener that…


Who is Chief Data Scientist DJ Patil? A skateboarding Silicon Valley nerd.

Who is Chief Data Scientist DJ Patil? A skateboarding Silicon Valley nerd.

April 10, 2015 1:48 pm by | 0 Comments

Recent White House appointee DJ Patil will lead up the big data plans that will be central to Obama’s Precision Medicine Initiative. But who is the guy? Yahoo News put together a…